Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study
Katia Bruxvoort, Lina S. Sy, Lei Qian, et al.
BMJ (2021), pp. e068848-e068848
Open Access | Times Cited: 221

Showing 1-25 of 221 citing articles:

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
Daniel R. Feikin, Melissa M. Higdon, Laith J. Abu‐Raddad, et al.
The Lancet (2022) Vol. 399, Iss. 10328, pp. 924-944
Open Access | Times Cited: 1082
SARS-CoV-2 variant biology: immune escape, transmission and fitness
Alessandro M. Carabelli, Thomas P. Peacock, Lucy Thorne, et al.
Nature Reviews Microbiology (2023)
Open Access | Times Cited: 937
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants
Emma K. Accorsi, Amadea Britton, Katherine E. Fleming-Dutra, et al.
JAMA (2022) Vol. 327, Iss. 7, pp. 639-639
Open Access | Times Cited: 643
Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
Hung Fu Tseng, Bradley K. Ackerson, Yi Luo, et al.
Nature Medicine (2022) Vol. 28, Iss. 5, pp. 1063-1071
Open Access | Times Cited: 491
Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022
Jill M. Ferdinands, Suchitra Rao, Brian E. Dixon, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 7, pp. 255-263
Open Access | Times Cited: 423
SARS-CoV-2 vaccine protection and deaths among US veterans during 2021
Barbara A. Cohn, Piera M. Cirillo, Caitlin C. Murphy, et al.
Science (2021) Vol. 375, Iss. 6578, pp. 331-336
Open Access | Times Cited: 241
Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults
Lianpan Dai, Lidong Gao, Lifeng Tao, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 22, pp. 2097-2111
Open Access | Times Cited: 222
Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022
Nana Wu, Keven Joyal‐Desmarais, Paula Aver Bretanha Ribeiro, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 5, pp. 439-452
Open Access | Times Cited: 187
Evaluation of Waning of SARS-CoV-2 Vaccine–Induced Immunity
Francesco Menegale, Mattia Manica, Agnese Zardini, et al.
JAMA Network Open (2023) Vol. 6, Iss. 5, pp. e2310650-e2310650
Open Access | Times Cited: 175
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study
Jill M. Ferdinands, Suchitra Rao, Brian E. Dixon, et al.
BMJ (2022), pp. e072141-e072141
Open Access | Times Cited: 162
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age
C. Buddy Creech, Evan J. Anderson, Vladimir Berthaud, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 21, pp. 2011-2023
Open Access | Times Cited: 142
Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis
Wing Ying Au, Peter Pak‐Hang Cheung
BMJ (2022), pp. e069989-e069989
Open Access | Times Cited: 126
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113
SARS‐CoV‐2 Omicron variant: Immune escape and vaccine development
Danyi Ao, Tianxia Lan, Xuemei He, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 105
Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons
Philip L. Tzou, Kaiming Tao, Sergei L. Kosakovsky Pond, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0261045-e0261045
Open Access | Times Cited: 93
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
Hung Fu Tseng, Bradley K. Ackerson, Katia Bruxvoort, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 90
SARS-CoV-2: Evolution and Emergence of New Viral Variants
Verónica Roxana Flores-Vega, Jessica Viridiana Monroy-Molina, Luis Enrique Jiménez-Hernández, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 653-653
Open Access | Times Cited: 85
Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance
Amadea Britton, Katherine E. Fleming-Dutra, Nong Shang, et al.
JAMA (2022) Vol. 327, Iss. 11, pp. 1032-1032
Open Access | Times Cited: 81
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Melissa M. Higdon, Brian Wahl, Carli B. Jones, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 6
Open Access | Times Cited: 81
Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study
Ulrikka Nygaard, Mette Holm, Ulla Birgitte Hartling, et al.
The Lancet Child & Adolescent Health (2022) Vol. 6, Iss. 7, pp. 459-465
Open Access | Times Cited: 76
An update on COVID-19: SARS-CoV-2 variants, antiviral drugs, and vaccines
V. Edwin Hillary, Stanislaus Antony Ceasar
Heliyon (2023) Vol. 9, Iss. 3, pp. e13952-e13952
Open Access | Times Cited: 76
Role of COVID-19 Vaccines in SARS-CoV-2 Variants
Zhou Zhou, Yimiao Zhu, Ming Chu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 73
Polymer nanoparticles deliver mRNA to the lung for mucosal vaccination
Alexandra Suberi, Molly K. Grun, Tianyang Mao, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 709
Open Access | Times Cited: 70
Durability of Vaccine-Induced and Natural Immunity Against COVID-19: A Narrative Review
Nick Pooley, Salim S. Abdool Karim, Béhazine Combadière, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 2, pp. 367-387
Open Access | Times Cited: 63
Page 1 - Next Page

Scroll to top